Differentiation of Effector/memory Vdelta2 T Cells and Migratory Routes in Lymph Nodes or Inflammatory Sites

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2003 Aug 6

PMID 12900516

Citations 150

Authors

Francesco Dieli

Fabrizio Poccia

Martin Lipp

Guido Sireci

Nadia Caccamo

Caterina Di Sano

Alfredo Salerno

Affiliations

Soon will be listed here.

Abstract

Vdelta2 T lymphocytes recognize nonpeptidic antigens without presentation by MHC molecules and mount both immediate effector functions and memory responses after microbial infection. However, how Vdelta2 T cells mediate different facets of a memory response remains unknown. Here, we show that the expression of CD45RA and CD27 antigens defines four subsets of human Vdelta2 T cells with distinctive compartmentalization routes. Naive CD45RA+CD27+ and memory CD45RA-CD27+ cells express lymph node homing receptors, abound in lymph nodes, and lack immediate effector functions. Conversely, memory CD45RA-CD27- and terminally differentiated CD45RA+CD27- cells, which express receptors for homing to inflamed tissues, are poorly represented in the lymph nodes while abounding at sites of inflammation, and display immediate effector functions. These observations and additional in vitro experiments indicate a lineage differentiation pattern for human Vdelta2 T cells that generates naive cells circulating in lymph nodes, effector/memory cells patrolling the blood, and terminally differentiated effector cells residing in inflamed tissues.

Citing Articles

The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defense.

Lo Presti E, Cupaioli F, Scimeca D, Unti E, Di Martino V, Daidone R Oncoimmunology. 2025; 14(1):2466301.

PMID: 39945298 PMC: 11834455. DOI: 10.1080/2162402X.2025.2466301.

Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy.

Bridge J, Johnson M, Kim J, Wenthe S, Krueger J, Wick B bioRxiv. 2024; .

PMID: 39464114 PMC: 11507710. DOI: 10.1101/2024.09.03.611042.

Epidermodysplasia Verruciformis and Vδ2 γδ T-cell Expansion in STK4 Deficiency.

Ying W, Long X, Vandergriff T, Karnati H, Heberton M, Chen M J Clin Immunol. 2024; 44(8):172.

PMID: 39110273 PMC: 11306306. DOI: 10.1007/s10875-024-01780-z.

Human γδ T cells in diverse tissues exhibit site-specific maturation dynamics across the life span.

Gray J, Caron D, Wells S, Guyer R, Szabo P, Rainbow D Sci Immunol. 2024; 9(96):eadn3954.

PMID: 38848342 PMC: 11425769. DOI: 10.1126/sciimmunol.adn3954.

Higher TIGIT+ γδ T cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML.

Hou Q, Wang P, Kong X, Chen J, Yao C, Luo X Front Immunol. 2024; 15:1321126.

PMID: 38711501 PMC: 11070478. DOI: 10.3389/fimmu.2024.1321126.

References

Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E . CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999; 99(1):23-33. DOI: 10.1016/s0092-8674(00)80059-8. View

Dieli F, Sireci G, Di Sano C, Romano A, Titone L, Di Carlo P . Ligand-specific alphabeta and gammadelta T cell responses in childhood tuberculosis. J Infect Dis. 1999; 181(1):294-301. DOI: 10.1086/315180. View

Dieli F, Troye-Blomberg M, Ivanyi J, Fournie J, Bonneville M, Peyrat M . Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol. 2000; 30(5):1512-9. DOI: 10.1002/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3. View

Morita C, Mariuzza R, Brenner M . Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol. 2000; 22(3):191-217. DOI: 10.1007/s002810000042. View

Sireci G, Espinosa E, Di Sano C, Dieli F, Fournie J, Salerno A . Differential activation of human gammadelta cells by nonpeptide phosphoantigens. Eur J Immunol. 2001; 31(5):1628-35. DOI: 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T. View

Gioia C, Agrati C, Casetti R, Cairo C, Borsellino G, Battistini L . Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J Immunol. 2002; 168(3):1484-9. DOI: 10.4049/jimmunol.168.3.1484. View

Shen Y, Zhou D, Qiu L, Lai X, Simon M, Shen L . Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science. 2002; 295(5563):2255-8. PMC: 2872146. DOI: 10.1126/science.1068819. View

Dieli F, Sireci G, Caccamo N, Di Sano C, Titone L, Romano A . Selective depression of interferon-gamma and granulysin production with increase of proliferative response by Vgamma9/Vdelta2 T cells in children with tuberculosis. J Infect Dis. 2002; 186(12):1835-9. DOI: 10.1086/345766. View

10.

Chen Z, Letvin N . Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm. Trends Immunol. 2003; 24(4):213-9. PMC: 2869283. DOI: 10.1016/s1471-4906(03)00032-2. View

11.

Parker C, Groh V, Band H, Porcelli S, Morita C, Fabbi M . Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med. 1990; 171(5):1597-612. PMC: 2187908. DOI: 10.1084/jem.171.5.1597. View

12.

Michie C, McLean A, Alcock C, Beverley P . Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 1992; 360(6401):264-5. DOI: 10.1038/360264a0. View

13.

Constant P, Davodeau F, Peyrat M, Poquet Y, Puzo G, Bonneville M . Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science. 1994; 264(5156):267-70. DOI: 10.1126/science.8146660. View

14.

Tanaka Y, Sano S, Nieves E, De Libero G, Rosa D, Modlin R . Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A. 1994; 91(17):8175-9. PMC: 44568. DOI: 10.1073/pnas.91.17.8175. View

15.

Lang F, Peyrat M, Constant P, Davodeau F, Poquet Y, Vie H . Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol. 1995; 154(11):5986-94. View

16.

Morita C, Tanaka Y, Nieves E, Brenner M, Bloom B . Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature. 1995; 375(6527):155-8. DOI: 10.1038/375155a0. View

17.

Burk M, Mori L, De Libero G . Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol. 1995; 25(7):2052-8. DOI: 10.1002/eji.1830250737. View

18.

Morita C, Beckman E, Bukowski J, Tanaka Y, Band H, Bloom B . Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity. 1995; 3(4):495-507. DOI: 10.1016/1074-7613(95)90178-7. View

19.

Li B, Rossman M, Imir T, Lee C, Biancaniello R, Carding S . Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol. 1996; 157(9):4222-9. View

20.

Hamann D, Baars P, Rep M, Hooibrink B, Klein M, van Lier R . Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997; 186(9):1407-18. PMC: 2199103. DOI: 10.1084/jem.186.9.1407. View